Literature DB >> 34772794

Lung Dose Measured on Postradioembolization 90Y PET/CT and Incidence of Radiation Pneumonitis.

Martina Stella1, Rob van Rooij2, Marnix G E H Lam2, Hugo W A M de Jong2, Arthur J A T Braat2.   

Abstract

Radiation pneumonitis is a rare but possibly fatal side effect of 90Y radioembolization. It may occur 1-6 mo after therapy, if a significant part of the 90Y microspheres shunts to the lungs. In current clinical practice, a predicted lung dose greater than 30 Gy is considered a criterion to exclude patients from treatment. However, contrasting findings regarding the occurrence of radiation pneumonitis and lung dose were previously reported in the literature. In this study, the relationship between the lung dose and the eventual occurrence of radiation pneumonitis after 90Y radioembolization was investigated.
Methods: We retrospectively analyzed 317 90Y liver radioembolization procedures performed during an 8-y period (February 2012 to September 2020). We calculated the predicted lung mean dose (LMD) using 99mTc-MAA planar scintigraphy (LMDMAA) acquired during the planning phase and left LMD (LMDY-90) using the 90Y PET/CT acquired after the treatment. For the lung dose computation, we used the left lung as the representative lung volume, to compensate for scatter from the liver moving in the craniocaudal direction because of breathing and mainly affecting the right lung.
Results: In total, 272 patients underwent 90Y procedures, of which 63% were performed with glass microspheres and 37% with resin microspheres. The median injected activity was 1,974 MBq (range, 242-9,538 MBq). The median LMDMAA was 3.5 Gy (range, 0.2-89.0 Gy). For 14 procedures, LMDMAA was more than 30 Gy. Median LMDY-90 was 1 Gy (range, 0.0-22.1 Gy). No patients had an LMDY-90 of more than 30 Gy. Of the 3 patients with an LMDY-90 of more than 12 Gy, 2 patients (one with an LMDY-90 of 22.1 Gy and an LMDMAA of 89 Gy; the other with an LMDY-90 of 17.7 Gy and an LMDMAA of 34.1 Gy) developed radiation pneumonitis and consequently died. The third patient, with an LMDY-90 of 18.4 Gy (LMDMAA, 29.1 Gy), died 2 mo after treatment, before the imaging evaluation, because of progressive disease.
Conclusion: The occurrence of radiation pneumonitis as a consequence of a lung shunt after 90Y radioembolization is rare (<1%). No radiation pneumonitis developed in patients with a measured LMDY-90 lower than 12 Gy.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  90Y PET dosimetry; 90Y radioembolization; 99mTc-MAA lung dose predicted; lung-dose; radiation pneumonitis

Mesh:

Substances:

Year:  2021        PMID: 34772794      PMCID: PMC9258566          DOI: 10.2967/jnumed.121.263143

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   11.082


  30 in total

Review 1.  ⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.

Authors:  Arthur J A T Braat; Maarten L J Smits; Manon N G J A Braat; Andor F van den Hoven; Jip F Prince; Hugo W A M de Jong; Maurice A A J van den Bosch; Marnix G E H Lam
Journal:  J Nucl Med       Date:  2015-05-07       Impact factor: 10.057

2.  Lung shunt and lung dose calculation methods for radioembolization treatment planning.

Authors:  S Cheenu Kappadath; Benjamin P Lopez; Riad Salem; Marnix G Lam
Journal:  Q J Nucl Med Mol Imaging       Date:  2021-01-04       Impact factor: 2.346

3.  Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients.

Authors:  Jennifer L Peterson; Laura A Vallow; Douglas W Johnson; Michael G Heckman; Nancy N Diehl; Ashley A Smith; Katherine S Tzou; Ricardo Paz-Fumagalli; Siyong Kim; Stephen J Ko; Larry C Daugherty; George P Kim; Norman Brown; Kurt W Mori; Steven J Buskirk
Journal:  Brachytherapy       Date:  2013-08-14       Impact factor: 2.362

4.  Calculation of lung mean dose and quantification of error for 90 Y-microsphere radioembolization using 99m Tc-MAA SPECT/CT and diagnostic chest CT.

Authors:  Benjamin Lopez; Armeen Mahvash; Marnix G E H Lam; S Cheenu Kappadath
Journal:  Med Phys       Date:  2019-06-11       Impact factor: 4.071

5.  A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver Tumors.

Authors:  Helmut Dittmann; Daniel Kopp; Juergen Kupferschlaeger; Diana Feil; Gerd Groezinger; Roland Syha; Matthias Weissinger; Christian la Fougère
Journal:  J Nucl Med       Date:  2018-01-25       Impact factor: 10.057

6.  A Comparison of Techniques for (90)Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres.

Authors:  Alexander S Pasciak; Austin C Bourgeois; Yong C Bradley
Journal:  Front Oncol       Date:  2014-05-22       Impact factor: 6.244

7.  Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization.

Authors:  Marco D'Arienzo; Maria Pimpinella; Marco Capogni; Vanessa De Coste; Luca Filippi; Emiliano Spezi; Nick Patterson; Francesca Mariotti; Paolo Ferrari; Paola Chiaramida; Michael Tapner; Alexander Fischer; Timo Paulus; Roberto Pani; Giuseppe Iaccarino; Marco D'Andrea; Lidia Strigari; Oreste Bagni
Journal:  EJNMMI Res       Date:  2017-11-28       Impact factor: 3.138

Review 8.  Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.

Authors:  Marta Cremonesi; Carlo Chiesa; Lidia Strigari; Mahila Ferrari; Francesca Botta; Francesco Guerriero; Concetta De Cicco; Guido Bonomo; Franco Orsi; Lisa Bodei; Amalia Di Dia; Chiara Maria Grana; Roberto Orecchia
Journal:  Front Oncol       Date:  2014-08-19       Impact factor: 6.244

Review 9.  Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.

Authors:  Joseph Ralph Kallini; Ahmed Gabr; Riad Salem; Robert J Lewandowski
Journal:  Adv Ther       Date:  2016-04-02       Impact factor: 3.845

Review 10.  The physics of radioembolization.

Authors:  Remco Bastiaannet; S Cheenu Kappadath; Britt Kunnen; Arthur J A T Braat; Marnix G E H Lam; Hugo W A M de Jong
Journal:  EJNMMI Phys       Date:  2018-11-02
View more
  1 in total

Review 1.  The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases.

Authors:  Khalil Ramdhani; Arthur J A T Braat
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.